Informations importantes sur EDTA

L’article EDTA: Ethylene Diamine Tetra Acetic Acid - A Review d’E. Blaurock-Busch a été publié dans la revue Occupational Medicine & Health Affairs (2016 4:4)

Les médecins du monde entier utilisant la thérapie par chélation intègrent des traitements à l’EDTA dans leur pratique quotidienne, souvent sans connaître les différences chimiques des divers agents chélateurs. Ces malentendus accroissent le risque d’accidents iatrogènes. Cette information a pour but de l’éviter.


Chelation Article Response

Summary of the response to Dr. Michael Gerber's article "Thirty Years of Progress in Cardiovascular Heath", Townsend Letter, Oct 2011: view

  • Studies indicate NaMgEDTA is successful in treating atherosclerotic disease.
  • EDTA is not a suitable chelating substance for mercury
  • In its oral form, EDTA only detoxifies the digestive tract
  • As a suppository, EDTA detoxifies the colon.
  • EDTA, provided orally or as a suppository, does not cause clinically or statistically significant metal binding within the blood stream.


Na2EDTA (Ethylene diamine tetraacetic acid disodium salt or in short Sodium EDTA) easily binds with calcium. It is used intravenously in the treatment of hypercalcemia and of atherosclerotic disease. Na2EDTA should not be used in children or patients suffering from parathyroid disease.

CaEDTA is the calcium salt of Ethylene diamine tetraacetic acid, also referred to as Calcium ethylenediamine tetra-acetic acid. Since it is bound to calcium, it will not be effective in removing calcium. It has been approved for lead intoxication only.

The infusion time of Na2EDTA or CaEDTA should not be less than 1gr/hr.

Oral EDTA or EDTA suppositories detoxify the digestive tract. Read more